However, because short peptides directly load onto MHC class I molecules, their efficacy is limited by HLA subtype restriction, most notably HLA-A*02:01, and recent evidence suggests that these epitopes may not be endogenously presented by DMG tumor cells, raising concerns about whether the induced T cells can effectively recognize and kill tumor cells [65]. The gene discussed is HLA-A; the disease is neoplasm.